Skip to Main Content

Paper Details

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes.
iScience
18
2020
High-Grade Serous Ovarian Cancer, Mesenchymal high-grade serous ovarian cancer, Tumor, cancer, homologous, homologous recombination deficient tumors, ovarian cancer, proteome
Author NameAffiliation
Stefani N ThomasClinical Chemistry Division, Johns Hopkins University School of Medicine
Michael SchnaubeltClinical Chemistry Division, Johns Hopkins University School of Medicine
Daniel W ChanClinical Chemistry Division, Johns Hopkins University School of Medicine
Daniel W ChanClinical Chemistry Division, Johns Hopkins University School of Medicine
Hui ZhangClinical Chemistry Division, Johns Hopkins University School of Medicine
Ruedi AebersoldInstitute of Molecular Systems Biology, ETH Zurich, University of Zurich
Ruedi AebersoldInstitute of Molecular Systems Biology, ETH Zurich, University of Zurich
  • 1 - 7

Datasets

Release 1.2